L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection

Brain Res. 1993 Oct 1;623(2):303-7. doi: 10.1016/0006-8993(93)91442-u.

Abstract

Rats receiving L-dopa/carbidopa (70 mg/kg/17.5 mg/kg, i.p.) 1 h prior to a single methamphetamine (m-AMPH) (4 mg/kg, s.c.) pretreatment showed an extraordinary striatal dopamine (DA) overflow into the extracellular space (30-60 times basal overflow) as compared to the DA overflow elicited by m-AMPH alone (4-5 times basal). Animals treated with L-dopa/carbidopa plus m-AMPH, but not m-AMPH alone, had substantial (60%) decreases in striatal DA content 1 week later. These findings support the conclusion that the magnitude of m-AMPH-induced DA overflow contributes to the degree of nerve terminal damage and highlight the importance of extracellular DA in striatal terminal damage.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Chromatography, High Pressure Liquid
  • Corpus Striatum / metabolism*
  • Dialysis
  • Dopamine / metabolism*
  • Drug Synergism
  • Electrochemistry
  • Injections
  • Levodopa / administration & dosage*
  • Levodopa / pharmacology
  • Male
  • Methamphetamine / pharmacology*
  • Nerve Endings / drug effects*
  • Nerve Endings / metabolism*
  • Nervous System / drug effects
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Methamphetamine
  • Levodopa
  • Dopamine